Literature DB >> 2825774

Purification and characterization of a type I DNA topoisomerase from calf thymus mitochondria.

G M Lazarus1, J P Henrich, W G Kelly, S A Schmitz, F J Castora.   

Abstract

A type I topoisomerase has been purified more than 4000-fold from calf thymus mitochondria. The enzyme is membrane associated and is effectively solubilized by 1% Triton X-100 treatment of purified mitochondrial inner membranes. This ATP-independent enzyme relaxes positively and negatively supercoiled DNA with delta LK = 1. At low ionic strength, the native enzyme appears to be a monomer (sedimentation coefficient of 4.3 S and Stokes radius of 34 A), but it can form a weakly associated dimer at higher salt concentrations (sedimentation coefficient of 7.0 S and Stokes radius of 47.5 A). The mitochondrial type I topoisomerase is distinguishable from the nuclear enzyme by its (1) pH profile, (2) thermal stability, (3) response to dimethyl sulfoxide and Berenil, and (4) molecular weight. The mitochondrial enzyme is inhibited by elevated concentrations of the bacterial DNA gyrase inhibitor novobiocin, but not nalidixic or oxolinic acids. Sensitivity to N-ethylmaleimide indicates the importance of cysteine for catalytic activity. It is estimated that there are at least five copies of topoisomerase I per mammalian mitochondrion or a minimum of one to two per mitochondrial genome. In a manner similar to that observed with leukemia (nuclear and mitochondrial), calf thymus (nuclear), and HeLa (nuclear) cell type I topoisomerase, the calf thymus mitochondrial enzyme is inhibited by physiological concentrations of ATP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2825774     DOI: 10.1021/bi00393a036

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  In vitro processing of mitochondrial and plastid derived tRNA precursors in a plant mitochondrial extract.

Authors:  A Marchfelder; W Schuster; A Brennicke
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

Review 2.  Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components.

Authors:  Alison E Barnhill; Matt T Brewer; Steve A Carlson
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

3.  Human mitochondrial topoisomerase I.

Authors:  H Zhang; J M Barceló; B Lee; G Kohlhagen; D B Zimonjic; N C Popescu; Y Pommier
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

4.  Evidence for the presence of 5S rRNA in mammalian mitochondria.

Authors:  P J Magalhães; A L Andreu; E A Schon
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

5.  Evidence for a nucleotide-dependent topoisomerase activity from yeast mitochondria.

Authors:  U R Ezekiel; E M Towler; J W Wallis; H P Zassenhaus
Journal:  Curr Genet       Date:  1994-12       Impact factor: 3.886

6.  Dual localization of human DNA topoisomerase IIIalpha to mitochondria and nucleus.

Authors:  Yong Wang; Yi Lisa Lyu; James C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-03       Impact factor: 11.205

Review 7.  Nucleus-driven mutations of human mitochondrial DNA.

Authors:  M Zeviani
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

8.  Heat stress induces hsc70/nuclear topoisomerase I complex formation in vivo: evidence for hsc70-mediated, ATP-independent reactivation in vitro.

Authors:  R P Ciavarra; C Goldman; K K Wen; B Tedeschi; F J Castora
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.